The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers
Open accessAbstract
The oral administration of therapeutic peptides and proteins is favoured from a patient and commercial point of view. In order to reach the systemic circulation after oral administration, these drugs have to overcome numerous barriers including the enzymatic, sulfhydryl, mucus and epithelial barrier. The development of oral formulations for therapeutic peptides and proteins is therefore necessary. Among the most promising formulation approaches are lipid-based nanocarriers such as oil-in-water nanoemulsions, self-emulsifying drug delivery systems (SEDDS), solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), liposomes and micelles. As the lipophilic character of therapeutic peptides and proteins can be tremendously increased such as by the formation of hydrophobic ion pairs (HIP) with hydrophobic counter ions, they can be incorporated in the lipophilic phase of these carriers. Since gastrointestinal (GI) peptidases as well as sulfhydryl compounds such as glutathione and dietary proteins are too hydrophilic to enter the lipophilic phase of these carriers, the incorporated therapeutic peptide or protein is protected towards enzymatic degradation as well as unintended thiol/disulfide exchange reactions. Stability of lipid-based nanocarriers towards lipases can be provided by the use to excipients that are not or just poorly degraded by these enzymes. Nanocarriers with a size <200 nm and a mucoinert surface such as PEG or zwitterionic surfaces exhibit high mucus permeating properties. Having reached the underlying absorption membrane, lipid-based nanocarriers enable paracellular and lymphatic drug uptake, induce endocytosis and transcytosis or simply fuse with the cell membrane releasing their payload into the systemic circulation. Numerous in vivo studies provide evidence for the potential of these delivery systems. Within this review we provide an overview about the different barriers for oral peptide and protein delivery, highlight the progress made on lipid-based nanocarriers in order to overcome them and discuss strengths and weaknesses of these delivery systems in comparison to other technologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–230 of 230
Wang, T., Wang, N., Hao, A., He, X., Li, T., & Deng, Y. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.01.006 · Cited by 40
Ramakrishna, B., Mathan, M., & Mathan, V. I. (1994) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529409090437 · Cited by 40
Zupančič, O., Rohrer, J., Lam, H. T., Grießinger, J. A., & Bernkop‐Schnürch, A. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1338722 · Cited by 40
Self-citationWibel, R., Friedl, J. D., Zaichik, S., & Bernkop‐Schnürch, A. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.04.004 · Cited by 38
Self-citationN-Octyl-N-Arginine Chitosan Micelles as an Oral Delivery System of Insulin
Zhang, Z., Abbad, S., Pan, R., et al. (2013) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2013.1572 · Cited by 36
Encapsulation of Protein-Polysaccharide HIP Complex in Polymeric Nanoparticles
Gaudana, R., Khurana, V., Parenky, A. C., & Mitra, A. K. (2011) · Journal of Drug Delivery · doi:10.1155/2011/458128 · Cited by 34
Li, Q., Xia, D., Tao, J., Shen, A., He, Y., Gan, Y., & Wang, C. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.05.029 · Cited by 33
Amphotericin B loaded SLN prepared with the coacervation technique
BIANCO, M. A., Gallarate, M., Trotta, M., & Battaglia, L. (2010) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(10)50028-5 · Cited by 32
Polyphosphate coatings: A promising strategy to overcome the polycation dilemma
Le, N. N., Steinbring, C., Le‐Vinh, B., Jalil, A., Matuszczak, B., & Bernkop‐Schnürch, A. (2020) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2020.12.019 · Cited by 32
Self-citationSimulation of fusion-mediated nanoemulsion interactions with model lipid bilayers
Lee, S.-J., Schlesinger, P. H., Wickline, S. A., Lanza, G. M., & Baker, N. (2012) · Soft Matter · doi:10.1039/c2sm25847a · Cited by 30
Preparation and evaluation of nattokinase-loaded self-double-emulsifying drug delivery system
Wang, X., Jiang, S., Wang, X., Liao, J., & Yin, Z. (2015) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2015.04.005 · Cited by 29
Liu, J., Hirschberg, C., Fanø, M., Mu, H., & Müllertz, A. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105272 · Cited by 29
Oral Insulin Delivery Using Poly (Styrene Co-Maleic Acid) Micelles in a Diabetic Mouse Model
Bahman, F., Taurin, S., Diab, D. E., Taha, S., Bakhiet, M., & Greish, K. F. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111026 · Cited by 29
Lupo, N., Steinbring, C., Friedl, J. D., Le‐Vinh, B., & Bernkop‐Schnürch, A. (2020) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2020.1851241 · Cited by 28
Self-citationDahlgren, D., Sjöblom, M., Hedeland, M., & Lennernäs, H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020099 · Cited by 26
Glargine insulin loaded lipid nanoparticles: Oral delivery of liquid and solid oral dosage forms
Muntoni, E., Anfossi, L., Milla, P., Marini, E., Ferraris, C., Capucchio, M. T., Colombino, E., Segale, L., Porta, M., & Battaglia, L. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.09.020 · Cited by 26
Arnold, Y. E., Imanidis, G., & Kuentz, M. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2011.645834 · Cited by 25
Solid Lipid Excipients as Matrix Agents for Sustained Drug Delivery
Rosiaux, Y., Jannin, V., Hughes, S., & Marchaud, D. (2015) · Springer eBooks · doi:10.1007/978-3-319-20206-8_9 · Cited by 25
Reprint of: Nanocarrier systems for oral drug delivery: Do we really need them?
Bernkop‐Schnürch, A. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.06.011 · Cited by 22
Self-citationLi, Y., & Zhu, C. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s125047 · Cited by 21
Prajapati, J. B., Verma, S. D., & Patel, A. A. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s124703 · Cited by 21
About the impact of superassociation of hydrophobic ion pairs on membrane permeability
Shahzadi, I., Nazir, I., Phan, T. N. Q., & Bernkop‐Schnürch, A. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.03.016 · Cited by 18
Self-citationKurpiers, M., Wolf, J. D., Spleis, H., et al. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.07.024 · Cited by 18
Phospholipid Micelles for Peptide Drug Delivery
Esparza, K., Jayawardena, D., & Önyüksel, H. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9516-5_4 · Cited by 17
Kubackova, J., Holas, O., Zbytovská, J., Vraníková, B., Zeng, G., Pávek, P., & Müllertz, A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040459 · Cited by 17
Bashyal, S., Seo, J., Keum, T., Noh, G., Lamichhane, S., Kim, J. H., Kim, C. H., Choi, Y. W., & Lee, S. K. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s318092 · Cited by 16
Tekeli, M. Ç., Aktaş, Y., & Çelebi, N. (2021) · Amino Acids · doi:10.1007/s00726-020-02926-0 · Cited by 15
Prüfert, F., Hering, U., Zaichik, S., Le, N. N., & Bernkop‐Schnürch, A. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119371 · Cited by 14
Self-citationLipophilic Arginine Esters: The Gateway to Preservatives without Side Effects
Shahzadi, I., Jalil, A., Asim, M. H., Hupfauf, A., Gust, R., Nelles, P., Knabl, L., & Bernkop‐Schnürch, A. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00610 · Cited by 14
Self-citationEtezadi, H., Maleki, A., Friedl, J. D., & Bernkop‐Schnürch, A. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119918 · Cited by 13
Self-citation
Cited by
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Xiao, W., Jiang, W., Chen, Z., Huang, Y., Mao, J., Zheng, W., Hu, Y., & Shi, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02107-5 · Cited by 449
Liposomes as biocompatible and smart delivery systems – the current state
Dymek, M., & Sikora, E. (2022) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2022.102757 · Cited by 392
Nanocarrier system: An emerging strategy for bioactive peptide delivery
Zhang, X., Li, X., Zhao, Y., Zheng, Q., Wu, Q., & Yu, Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1050647 · Cited by 63
Local and Systemic Peptide Therapies for Soft Tissue Regeneration: A Narrative Review
Cushman, C. J., Ibrahim, A. F., Smith, A. D., Hernandez, E. J., MacKay, B., & Zumwalt, M. (2024) · The Yale Journal of Biology and Medicine · doi:10.59249/tknm3388 · Cited by 12
“Recently, the number of oral peptide formula - tions in clinical trials has been increasing due to oral drug delivery being a widely preferred method [18].”
Metadata
- Authors
- Haddadzadegan, S., Dorkoosh, F., & Bernkop-Schnürch, A.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2022-03
- Volume
- 182
- Pages
- 114097
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W4206360286
- Cited by
- 424
- References
- 230
- FWCI
- 6.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.